Denali Therapeutics (4DN.F) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.77
-0.69
-0.62
-0.55

Details

Expected EPS
-0.61146735387
Actual EPS
-0.6198551999999999
Surprise EPS
-0.01
Surprise Percent
+1.37%

Description

Denali Therapeutics (4DN.F) has reported earnings of -0.6198551999999999 per share for Q3 2025.

0 Comments

Share your thoughts